Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1/STAT1 activation
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 472, 40-49
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (16JCYBJC26300, 81872254)
- Society of Australasian Social Psychologists (26,34,35, 31,32)
- National Youth Foundation of China (81902900)
This publication has 36 references indexed in Scilit:
- Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulationProceedings of the National Academy of Sciences, 2013
- Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary resultsJournal of Neuroinflammation, 2012
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentNature, 2011
- Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin ProdrugMolecular Pharmaceutics, 2011
- Transcriptional regulation of macrophage polarization: enabling diversity with identityNature Reviews Immunology, 2011
- Macrophages, innate immunity and cancer: balance, tolerance, and diversityCurrent Opinion in Immunology, 2010
- The resolution of inflammation and cancerCytokine & Growth Factor Reviews, 2010
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- Targeting tumor-associated macrophages as a novel strategy against breast cancerJournal of Clinical Investigation, 2006
- Legumain Expression in Relation to Clinicopathologic and Biological Variables in Colorectal CancerClinical Cancer Research, 2005